Home › Compare › SRMMF vs JNJ

SRMMF vs JNJ: Dividend Comparison 2026

SRMMF yields 8000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRMMF wins by $6139401296821770.00M in total portfolio value
10 years
SRMMF
SRMMF
● Live price
8000.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6139401296821770.00M
Annual income
$5,992,060,180,362,265,000,000.00
Full SRMMF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SRMMF vs JNJ

📍 SRMMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRMMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRMMF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SRMMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRMMF
Annual income on $10K today (after 15% tax)
$680,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,093,251,153,307,925,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SRMMF beats the other by $5,093,251,153,307,925,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRMMF + JNJ for your $10,000?

SRMMF: 50%JNJ: 50%
100% JNJ50/50100% SRMMF
Portfolio after 10yr
$3069700648410885.00M
Annual income
$2,996,030,090,181,132,400,000.00/yr
Blended yield
97.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SRMMF
No analyst data
Altman Z
-80.9
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRMMF buys
0
JNJ buys
0
No recent congressional trades found for SRMMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRMMFJNJ
Forward yield8000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$6139401296821770.00M ✓$20.0K
Annual income after 10y$5,992,060,180,362,265,000,000.00 ✓$827.78
Total dividends collected$6129555735022888.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SRMMF vs JNJ ($10,000, DRIP)

YearSRMMF PortfolioSRMMF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$810,700$800,000.00$10,676$355.77+$800.0K → SRMMF
2$61,480,533$60,613,084.11$11,407$389.39+$61.47M → SRMMF
3$4,361,742,463$4,295,958,292.40$12,198$426.53+$4361.73M → SRMMF
4$289,505,553,392$284,838,488,956.41$13,056$467.62+$289505.54M → SRMMF
5$17,978,762,985,621$17,668,992,043,491.98$13,987$513.12+$17978762.97M → SRMMF
6$1,044,726,039,031,441$1,025,488,762,636,826.10$14,998$563.56+$1044726039.02M → SRMMF
7$56,809,462,631,941,760$55,691,605,770,178,120.00$16,098$619.52+$56809462631.93M → SRMMF
8$2,891,032,380,267,701,000$2,830,246,255,251,523,600.00$17,295$681.69+$2891032380267.68M → SRMMF
9$137,701,977,999,537,290,000$134,608,573,352,650,870,000.00$18,599$750.82+$137701977999537.28M → SRMMF
10$6,139,401,296,821,770,000,000$5,992,060,180,362,265,000,000.00$20,022$827.78+$6139401296821770.00M → SRMMF

SRMMF vs JNJ: Complete Analysis 2026

SRMMF — Stock

Sarama Resources Ltd, an exploration stage company, engages in the sourcing, exploration, and development of gold deposits in West Africa. The company holds 100% interest in the Sanutura Project covering an area of approximately 1,420 square kilometers; and 18% interest in the Karankasso Project covering an area of approximately 700 square kilometers located within the southern Houndé Belt, south-west Burkina Faso. It also holds 100% interest in the Koumandara Project comprises four exploration properties covering an area of approximately 467 square kilometers located within the northern Banfora Greenstone Belt, south-west Burkina Faso. The company was incorporated in 2010 and is headquartered in Subiaco, Australia.

Full SRMMF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SRMMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRMMF vs SCHDSRMMF vs JEPISRMMF vs OSRMMF vs KOSRMMF vs MAINSRMMF vs ABBVSRMMF vs MRKSRMMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.